Carvacrol, an aromatic plant-derived natural product, induces G1 arrest of breast cancer cells by suppressing CDK4, CDK6, pRB, and cyclin D1 expressions, accompanied by down-regulating PI3/AKT [438]. This evidence concerns the gene AKT1 and breast cancer.